» Articles » PMID: 24878679

Genome-wide Screening of Copy Number Variants in Children Born Small for Gestational Age Reveals Several Candidate Genes Involved in Growth Pathways

Overview
Specialty Endocrinology
Date 2014 Jun 1
PMID 24878679
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The etiology of prenatal-onset short stature with postnatal persistence is heterogeneous. Submicroscopic chromosomal imbalances, known as copy number variants (CNVs), may play a role in growth disorders.

Objective: To analyze the CNVs present in a group of patients born small for gestational age (SGA) without a known cause.

Patients And Methods: A total of 51 patients with prenatal and postnatal growth retardation associated with dysmorphic features and/or developmental delay, but without criteria for the diagnosis of known syndromes, were selected. Array-based comparative genomic hybridization was performed using DNA obtained from all patients. The pathogenicity of CNVs was assessed by considering the following criteria: inheritance; gene content; overlap with genomic coordinates for a known genomic imbalance syndrome; and overlap with CNVs previously identified in other patients with prenatal-onset short stature.

Results: In 17 of the 51 patients, 18 CNVs were identified. None of these imbalances has been reported in healthy individuals. Nine CNVs, found in eight patients (16%), were categorized as pathogenic or probably pathogenic. Deletions found in three patients overlapped with known microdeletion syndromes (4q, 10q26, and 22q11.2). These imbalances are de novo, gene rich and affect several candidate genes or genomic regions that may be involved in the mechanisms of growth regulation.

Conclusion: Pathogenic CNVs in the selected patients born SGA were common (at least 16%), showing that rare CNVs are probably among the genetic causes of short stature in SGA patients and revealing genomic regions possibly implicated in this condition.

Citing Articles

Clinical and Genetic Characterization of a Cohort of Small-for-Gestational-Age Patients: Cost-Effectiveness of Whole-Exome Sequencing and Effectiveness of Treatment with GH.

Arroyo-Ruiz R, Urbano-Ruiz C, Garcia-Berrocal M, Marcos-Vadillo E, Isidoro-Garcia M, Martin-Alonso M J Clin Med. 2024; 13(14).

PMID: 39064046 PMC: 11277664. DOI: 10.3390/jcm13144006.


Unravelling short stature in pediatrics: the crucial role of genetic perspective.

Martinez-Monseny A Transl Pediatr. 2024; 13(5):864-868.

PMID: 38840673 PMC: 11148743. DOI: 10.21037/tp-24-46.


Comprehensive assessment of the genetic characteristics of small for gestational age newborns in NICU: from diagnosis of genetic disorders to prediction of prognosis.

Xiao H, Chen H, Chen X, Lu Y, Wu B, Wang H Genome Med. 2023; 15(1):112.

PMID: 38093364 PMC: 10717355. DOI: 10.1186/s13073-023-01268-2.


A Genetic Approach in the Evaluation of Short Stature.

Turkyilmaz A, Donmez A, Cayir A Eurasian J Med. 2023; 54(Suppl1):179-186.

PMID: 36655465 PMC: 11163345. DOI: 10.5152/eurasianjmed.2022.22171.


International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood.

Hokken-Koelega A, van der Steen M, Boguszewski M, Cianfarani S, Dahlgren J, Horikawa R Endocr Rev. 2023; 44(3):539-565.

PMID: 36635911 PMC: 10166266. DOI: 10.1210/endrev/bnad002.